Pharma · Global · 28 protocols
Clinical-trial chain-of-custody, proven to the regulator.
A top-5 global pharma needed defensible chain-of-custody and cold-chain integrity across 28 trial protocols.
The challenge
What they were up against.
Paper chain-of-custody
Custody for trial kits was paper-based and slow to reconstruct for audit.
Cold-chain risk
Temperature excursions risked the loss of high-value batches.
Weak audit readiness
21 CFR Part 11 audit readiness was inconsistent across protocols.
Our approach
Vendor-neutral, outcome-led.
We delivered continuous temperature, shock and location logging with sealed chain-of-custody and 21 CFR Part 11 electronic records, sharing events via EPCIS across 28 protocols.
How we solved it
What we delivered.
- Continuous temperature, shock and location logging
- Sealed chain-of-custody from depot to site to patient
- 21 CFR Part 11 e-records plus EPCIS sharing
Results
The outcome the board saw.
28
Trial protocols
21 CFR
Part 11
Global
Distribution
Audit
Defensible
Technology used
The stack behind it
RFID loggersCellular trackersEPCIS
Last updated: